T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells

被引:395
作者
Fahlén, L
Read, S
Gorelik, L
Hurst, SD
Coffman, RL
Flavell, RA
Powrie, F
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
[3] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA
[4] Dynavax Technol Corp, Albany, CA 94710 USA
基金
英国惠康基金;
关键词
D O I
10.1084/jem.20040685
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) regulatory T (T reg) cells play a pivotal role in control of the immune response. Transforming growth factor-beta (TGF-beta) has been shown to be required for T reg cell activity; however, precisely how it is involved in the mechanism of suppression is poorly understood. Using the T cell transfer model of colitis, we show here that CD4(+)CD45RB(high) T cells that express a dominant negative TGF-beta receptor type II (dnT beta RII) and therefore cannot respond to TGF-beta, escape control by T reg cells in vivo. CD4(+)CD25(+) T reg cells from the thymus of dnT beta RII mice retain the ability to inhibit colitis, suggesting that T cell responsiveness to TGF-beta is not required for the development or peripheral function of thymic-derived T reg cells. In contrast, T reg cell activity among the peripheral dnT beta RII CD4(+)CD25(+) population is masked by the presence of colitogenic effector cells that cannot be suppressed. Finally, we show that CD4(+)CD25(+) T reg cells develop normally in the absence of TGF-beta 1 and retain the ability to suppress colitis in vivo. Importantly, the function of TGF-beta 1(-/-) T reg cells was abrogated by anti-TGF-beta monoclonal antibody, indicating that functional TGF-beta can be provided by a non-T reg cell source.
引用
收藏
页码:737 / 746
页数:10
相关论文
共 49 条
  • [1] An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
    Asseman, C
    Mauze, S
    Leach, MW
    Coffman, RL
    Powrie, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 995 - 1003
  • [2] Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice:: Control by CD4+ regulatory T cells and IL-10
    Asseman, C
    Read, S
    Powrie, F
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (02) : 971 - 978
  • [3] TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes
    Belghith, M
    Bluestone, JA
    Barriot, S
    Mégret, J
    Bach, JF
    Chatenoud, L
    [J]. NATURE MEDICINE, 2003, 9 (09) : 1202 - 1208
  • [4] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    [J]. NATURE, 2002, 420 (6915) : 502 - 507
  • [5] Transforming growth factor β blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation
    Chen, CH
    Seguin-Devaux, C
    Burke, NA
    Oriss, TB
    Watkins, SC
    Clipstone, N
    Ray, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (12) : 1689 - 1699
  • [6] Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
    Chen, WJ
    Jin, WW
    Hardegen, N
    Lei, KJ
    Li, L
    Marinos, N
    McGrady, G
    Wahl, SM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) : 1875 - 1886
  • [7] Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants
    Cobbold, SP
    Castejon, R
    Adams, E
    Zelenika, D
    Graca, L
    Humm, S
    Waldmann, H
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10) : 6003 - 6010
  • [8] THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO
    COBBOLD, SP
    JAYASURIYA, A
    NASH, A
    PROSPERO, TD
    WALDMANN, H
    [J]. NATURE, 1984, 312 (5994) : 548 - 551
  • [9] Coffman R L, 1982, Immunol Rev, V69, P5
  • [10] Thrombospondin-1 is a major activator of TGF-β1 in vivo
    Crawford, SE
    Stellmach, V
    Murphy-Ullrich, JE
    Ribeiro, SMF
    Lawler, J
    Hynes, RO
    Boivin, GP
    Bouck, N
    [J]. CELL, 1998, 93 (07) : 1159 - 1170